Table of Contents
- What To Know About Nattokinase Dosage and FU
- What Are the Studied Nattokinase Doses?
- Does Low-Dose Nattokinase Really Work?
- The Full Clinical Evidence on Nattokinase Dosage
- What Is the Recommended Nattokinase Dosage?
- How to Read a Nattokinase Supplement Label
- Important Safety Considerations
- The Bottom Line on Nattokinase Dosage
- FAQs
Quick Answer
Clinically effective nattokinase dosage for lipid and atherosclerotic plaque support is 10,800 FU per day
Based on: 12-month study, 1,062 participants (Chen et al., 2022)
Market standard: 2,000 FU (5.4x below clinical dose)
3,600 FU/day was tested and found ineffective for lipids and atherosclerotic plaque support
Minimum threshold for modest blood pressure support: 2,000 FU/day
Getting the nattokinase dosage right is the single biggest factor in whether supplementation delivers real results. Nattokinase is a fibrinolytic enzyme originally identified in natto, a traditional Japanese fermented soybean food. These days, it’s become a hot topic for its potential benefits for blood flow, lipid balance, and overall cardiovascular health.
Determining the right nattokinase dosage can be confusing because supplements are often labeled in milligrams, fibrinolytic units (FU), or both. Because its activity is what researchers are interested in, FU is generally more useful than milligrams when comparing nattokinase supplements.
If you've been researching nattokinase, you've probably noticed something frustrating: every product seems to list a different dose, and none of them explain why they chose that number. Walk into any supplement aisle — or scroll through any online store — and you'll find nattokinase products ranging from 1,000 FU to 4,000 FU per serving. Most cluster around 2,000 FU.
That number isn't based on clinical research. It's based on manufacturing economics. And a landmark 2022 study involving over 1,000 participants has now shown exactly why that matters: the nattokinase dosage you take determines whether it actually works — or whether you're paying for an expensive placebo.
Human research has evaluated several nattokinase dosages, with 2,000 FU per day appearing frequently in randomized clinical trials. Higher amounts, including 10,800 FU daily, have also been studied, but the strength and type of evidence differ considerably. There is currently no universally established medical dose of nattokinase, so the clinically relevant dose depends on what the research actually supports.
What To Know About Nattokinase Dosage and FU
Most nattokinase supplements contain 2,000 FU (fibrinolytic units) per serving - an industry default based on manufacturing economics, not clinical research. The clinically studied dosage for full cardiovascular support is 10,800 FU, making the standard dose 5.4x below what research supports. This underscores why nattokinase dosage is such a critical consideration.
The clinically studied dosage of nattokinase is 10,800 fibrinolytic units (FU), significantly higher than the 2,000 FU found in most commercial supplements.
Product Category | Typical Dose | Clinical Dose | How Far Below |
Budget supplements | 1,000 FU | 10,800 FU | 10.8x below |
Standard supplements | 2,000 FU | 10,800 FU | 5.4x below |
"Premium" supplements | 4,000 FU | 10,800 FU | 2.7x below |
Clinical-dose products | 10,800 FU | 10,800 FU | Matched |
Think of it this way: if a clinical study tested a medication at 100 mg and found it effective, you wouldn't expect a 20 mg version to produce the same results. The same logic applies to enzyme supplements like nattokinase. Potency is not a marketing term here - it's the difference between a physiologically active dose and an expensive placebo. Getting the right nattokinase dosage can make the difference between results and disappointment.
Related reading: Best Time to Take Nattokinase
The problem is compounded by how nattokinase is measured. Unlike most supplements where milligrams tell the story, nattokinase potency is measured in Fibrinolytic Units (FU) - a standardized test of enzymatic activity. Two products can both say "100 mg nattokinase" while delivering wildly different FU counts. If you're not reading the FU number on the label, you have no idea what you're actually getting.
Related reading: The Truth About Cholesterol and Heart Disease
FU measures the enzyme's fibrinolytic activity. This is important because nattokinase is primarily studied for its ability to interact with fibrin, a protein involved in normal blood clot formation and breakdown. That's why looking only at milligrams doesn't tell you everything about the activity of a nattokinase supplement. FU provides a more useful measurement when comparing the amounts used in clinical research.
What Are the Studied Nattokinase Doses?
One of the most commonly researched nattokinase dosages is 2,000 FU per day, but this dose is thought to be much less effective than 10,800 FU. In a randomized, double-blind, placebo-controlled trial, 86 adults with untreated prehypertension or stage 1 hypertension received either nattokinase at 2,000 FU daily or placebo for eight weeks.
Among the 73 participants who completed the study, researchers observed modest reductions in systolic and diastolic blood pressure in the nattokinase group compared with placebo.
This study is particularly useful when discussing nattokinase dosage because it was randomized and placebo-controlled, giving the 2,000 FU amount clinically relevant human evidence. This does not mean that 2,000 FU has been established as a treatment for hypertension or that everyone should take this amount. The study investigated a particular population and outcome over a relatively short period.
Other clinical studies have used as much as 10,800 FU daily, and studies using the higher dosage seem to report more noteworthy effects.
The 10,800 FU Difference
Nattokinase at 10,800 FU per day significantly reduced atherosclerosis and improved lipid profiles, while 3,600 FU per day was ineffective. That's the central finding from the largest nattokinase clinical study to date. The evidence consistently points back to nattokinase dosage as the key variable.
The Chen et al., 2022 clinical study, published in Frontiers in Cardiovascular Medicine, enrolled 1,062 participants, over 12 months, is the strongest evidence we have on nattokinase dosage. Participants had atherosclerosis and hyperlipidemia, and the study was properly powered - not a small pilot trial.
A 2022 clinical study of 1,062 participants found that nattokinase at 10,800 FU per day significantly reduced atherosclerosis and improved lipid profiles, while a lower dose of 3,600 FU per day was ineffective - demonstrating a clear dose-response relationship.
Here's what the study found:
10,800 FU per day: Significantly reduced atherosclerotic plaque, improved total cholesterol, triglycerides, and LDL levels over 12 months.
3,600 FU per day: Ineffective - showed no significant improvement in lipid profiles or atherosclerosis markers compared to baseline.
No serious adverse events: The 10,800 FU dose was well-tolerated across all 1,062 participants with no serious side effects reported.
This finding is critical because 3,600 FU is already higher than what most commercial supplements provide. If 3,600 FU wasn't enough to produce results, what does that say about the standard 2,000 FU product? Without adequate nattokinase dosage, the expected benefits may not materialise.
Key finding: 2,000 FU delivers less than one-fifth of the clinically effective nattokinase dose of 10,800 FU per day.
Does Low-Dose Nattokinase Really Work?
Low-dose nattokinase supplementation has no significant lipid-lowering effect and may actually worsen dyslipidemia. That's the conclusion from The Li et al., 2023 systematic review and meta-analysis, published in Reviews in Cardiovascular Medicine, enrolled 546 participants, which analyzed data from multiple nattokinase clinical trials. This underscores why nattokinase dosage is such a critical consideration.
A 2023 systematic review and meta-analysis found that low-dose nattokinase supplementation had no significant lipid-lowering effect and may have even worsened dyslipidemia, reinforcing the importance of clinically validated higher doses.
The meta-analysis did find consistent blood pressure benefits across studies, with nattokinase reducing systolic blood pressure by an average of 3.45 mmHg and diastolic blood pressure by 2.32 mmHg. But for the lipid-lowering effects that many people take nattokinase for - cholesterol, triglycerides, atherosclerosis markers - dose matters enormously. Getting the right nattokinase dosage can make the difference between results and disappointment.
This creates a clear picture: if you're taking nattokinase primarily for blood pressure support, lower doses may offer some benefit. But if you're looking for the full range of cardiovascular effects - fibrinolysis, lipid management, and atherosclerosis protection - the evidence consistently points to 10,800 FU. These findings have direct implications for choosing the right nattokinase dosage.
Key finding: Low-dose nattokinase showed no significant lipid-lowering effect in a 2023 systematic review and meta-analysis.
The Full Clinical Evidence on Nattokinase Dosage
The Chen 2022 study didn't emerge in a vacuum. It built on decades of research stretching back to the original discovery of nattokinase in 1987. Here's how the key studies inform our understanding of nattokinase dosage:
Single-dose fibrinolytic activity: The Kurosawa et al., 2015 clinical study, published in Scientific Reports, demonstrated that a single oral dose of nattokinase enhanced fibrinolytic activity and showed anti-coagulation effects in healthy volunteers. It was the first study to confirm that oral nattokinase is absorbed intact and retains its clot-dissolving activity in the bloodstream.
Blood pressure reduction: The Kim et al., 2008 randomized controlled trial, published in Hypertension Research, enrolled 86 participants, over 8 weeks, found that participants taking nattokinase experienced a reduction in systolic blood pressure of 5.55 mmHg compared to placebo.
A 2008 randomized controlled trial published in Hypertension Research found that nattokinase supplementation reduced systolic blood pressure by an average of 5.55 mmHg compared to placebo over 8 weeks.
Clotting factor reduction: The Hsia et al., 2009 clinical study, published in Nutrition Research, enrolled 45 participants, over 8 weeks, found that nattokinase decreased plasma levels of fibrinogen, factor VII, and factor VIII - all key players in the clotting cascade. These are the same markers that physicians monitor for cardiovascular risk assessment.
Atherosclerotic plaque reduction: The Ren et al., 2017 clinical study, published in Zhonghua Yi Xue Za Zhi, over 26 weeks, found that nattokinase supplementation reduced carotid plaque size by 36.6% - a remarkable result that the Chen 2022 study later confirmed and extended with its larger population.
Vascular health markers: The Jensen et al., 2016 clinical study, published in Integrated Blood Pressure Control, enrolled 79 participants, over 8 weeks, showed that nattokinase consumption was associated with reduced von Willebrand factor (a clotting protein) by 15% in hypertensive patients, alongside blood pressure reduction.
Study | Dosage | Duration | Participants | Key Finding |
10,800 FU/day | 12 months | 1,062 | Reduced atherosclerosis + improved lipids | |
3,600 FU/day | 12 months | 1,062 | Ineffective for lipids | |
2,000 FU | Single dose | Healthy adults | Enhanced fibrinolytic activity | |
6,000 FU/day | 26 weeks | Atherosclerosis patients | 36.6% plaque reduction | |
2,000 FU/day | 8 weeks | 86 | BP reduced by 5.55 mmHg | |
4,000 FU/day | 8 weeks | 45 | Reduced clotting factors | |
100 mg/ day | 8 weeks | 79 | vWF reduced by 15% |
What Is the Recommended Nattokinase Dosage?
The evidence-based nattokinase dosage is 10,800 FU per day for comprehensive cardiovascular support, based on the largest clinical study to date.
For comprehensive cardiovascular support (fibrinolysis + lipids + atherosclerosis protection): 10,800 FU per day, taken as a single serving. This is the dose used in the landmark Chen 2022 study.
The largest nattokinase clinical study to date, involving 1,062 participants over 12 months, found that 10,800 FU per day effectively managed atherosclerosis progression and hyperlipidemia (Chen et al., Frontiers in Cardiovascular Medicine, 2022).
This doesn't mean lower doses do absolutely nothing. But if you're supplementing with nattokinase because you want the cardiovascular effects described in the research, the evidence is clear: 10,800 FU per day is the clinically validated threshold for the full spectrum of benefits.
How to Read a Nattokinase Supplement Label
Nattokinase labels can be deliberately confusing. Here's exactly what to look for to evaluate whether a product delivers a meaningful nattokinase dosage:
1. Look for FU, Not Milligrams
Milligrams tell you the weight of the powder in the capsule. Fibrinolytic Units (FU) tell you how much enzymatic activity that powder delivers. Two products could both contain 100 mg of nattokinase but deliver wildly different FU counts depending on enzyme purity and manufacturing quality. FU is the only metric that matters for efficacy.
Fibrinolytic Units (FU) measure the enzyme's ability to dissolve fibrin clots under standardized conditions. FU is the only validated metric for comparing nattokinase potency across products.
2. Calculate Total FU Per Daily Serving
Some labels list FU per capsule and recommend two or three capsules per serving. Others list FU per serving. Some particularly misleading labels list FU per bottle. Always calculate: what is the total FU I get in one day's recommended serving? Then compare that number to the 10,800 FU clinical benchmark.
3. Look for Third-Party Testing
Enzyme activity can degrade during manufacturing and storage. Products with third-party testing (NSF, USP, or independent lab verification) provide more confidence that what's on the label matches what's in the product. Some nattokinase products have been found to deliver significantly less than their labeled potency when independently tested.
4. Check the Fermentation Source
Nattokinase can be derived from soy-based or soy-free (chickpea) fermentation, with identical enzymatic activity regardless of substrate. If you have a soy allergy, thyroid concerns, or a preference for soy-free products, look for nattokinase derived from chickpea fermentation. The enzymatic activity is identical regardless of the fermentation substrate.
Important Safety Considerations
Nattokinase at 10,800 FU per day has a strong safety record. In the Chen 2022 study, 1,062 participants took this dose for a full 12 months with no serious adverse events reported.
Clinical studies on nattokinase have demonstrated a strong safety profile with no serious adverse events reported at dosages up to 10,800 FU per day in healthy adults, though it should not be combined with anticoagulant medications without medical supervision.
That said, important cautions apply:
Do not combine with blood thinners (warfarin, heparin, aspirin) without consulting your physician. Nattokinase has fibrinolytic activity that could amplify anticoagulant effects.
Discontinue before surgery. Most practitioners recommend stopping nattokinase at least two weeks before any scheduled procedure.
Consult your doctor if pregnant or nursing. There is insufficient safety data in these populations.
Talk to your doctor if you take blood pressure medication. Nattokinase may have additive blood-pressure-lowering effects.
The Bottom Line on Nattokinase Dosage
Supplements don't come in standard dosages because, as a rule, there is no exact recommended dosage of a supplement. Many nattokinase studies used lower doses (2,000 FU daily), but current research suggests that 10,800 FU may be a more effective daily dose for those actively seeking tangible support from nattokinase. Toku Flow is formulated at 10,800 FU per serving to mimic the clinical research with the best outcomes.
FAQs
Why do most nattokinase supplements only contain 2,000 FU?
The 2,000 FU standard is based on manufacturing economics rather than actual clinical evidence. Formulas that are more potent require significantly more raw material per serving, which, in turn, raises production costs. Many brands optimize their formulas for price point rather than clinical efficacy, and this is why most nattokinase products on the market end up offering far below the dose used in the most meaningful research (10,800 FU).
Is the ideal nattokinase dosage the same for everyone?
There’s no universally established dose that applies to every person, but the 10,800 FU dose is supported by the largest human nattokinase study to date and is the most clinically meaningful benchmark currently available. Individual factors, like your health status, medications, and cardiovascular risk profile, should be discussed with your healthcare provider before you start a new form of supplementation.
What does FU mean in nattokinase supplements?
FU stands for fibrinolytic units, a measurement of nattokinase's enzyme activity. Because supplements can differ in potency, FU is generally more informative than milligrams alone when comparing nattokinase products or matching a supplement to amounts evaluated in research.
How long does it take for nattokinase to work?
Research suggests that nattokinase reaches peak serum concentration around 13 hours after ingestion, with measurable fibrinolytic activity being shown around eight hours post-dose. Longer-term effects on lipids and atherosclerosis markers were observed over 12 months in the Chen et al. 2022 study. Consistency over time matters more than any single dose.
Can you take nattokinase every day?
Yes, you can take nattokinase every day. In fact, staying consistent with your daily dose is the best way to optimize your results. The largest human nattokinase study followed 1,062 participants taking 10,800 FU daily for 12 months with no serious adverse events reported. Always consult your healthcare provider before starting any new daily supplement.
Is soy-free nattokinase as effective as soy-based nattokinase?
Yes. Nattokinase derived from chickpea fermentation has identical enzymatic activity to soy-based nattokinase. The enzyme is produced by Bacillus subtilis regardless of the fermentation substrate, making soy-free nattokinase a completely effective option for people with soy allergies or sensitivities, or those who just prefer soy-free products in general.
*The information provided in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives. This content has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure or prevent any disease.
Sources:
